November 2, 2026 · Pain · DOI: 10.1097/j.pain.0000000000004081

The neuropathic chameleon: we are hot on the scent.

Listen to this summary

This review addresses why neuropathic pain treatments have largely failed, pointing to the condition's heterogeneous, mechanism-driven pathophysiology rather than its disease etiology. The authors ask how mechanism-based phenotyping could enable a priori patient stratification, given that no validated biomarkers for pain mechanisms currently exist. They evaluate candidate predictive and surrogate markers, focusing on sensory symptoms and signs assessed through patient-reported outcomes and quantitative sensory testing, and discuss how these could be integrated into future clinical trials.

Dilara Kersebaum, Julia Forstenpointner, Juliane Sachau, Philipp Hüllemann, Ralf Baron

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play